Is it your opinion that this recent announcement by Alcon to initiate the Retanne study could impact (good or bad) current interest in "big pharma" signing a deal with GENR?
BTW ...I share your opinion with respect to Merck and their need to look at companies like GENR if they want to compete with other big drug companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.